RGEN Q3 2020 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q3 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$94M+35.4% YoY

Gross Profit

$54M57.9% margin

Operating Income

$22M23.3% margin

Net Income

$15M15.5% margin

EPS (Diluted)

$0.27

QoQ Revenue Growth

+7.5%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$16M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$351M

Stockholders' Equity

$1.1B

Cash & Equivalents

$553M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$69M	+35.4%
Gross Profit	$54M	$38M	+43.2%
Operating Income	$22M	$8M	+175.8%
Net Income	$15M	$2M	+777.2%

Revenue Segments

Product

$94M100%

Royalty

$31,0000%